Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

QuintilesIMS
Argus Health
Chubb
Teva
Harvard Business School
Federal Trade Commission
Cipla
Queensland Health
Fish and Richardson
Novartis

Generated: August 19, 2017

DrugPatentWatch Database Preview

Tolterodine tartrate - Generic Drug Details

« Back to Dashboard

What are the generic drug sources for tolterodine tartrate and what is the scope of tolterodine tartrate patent protection?

Tolterodine tartrate
is the generic ingredient in three branded drugs marketed by Ivax Sub Teva Pharms, Macleods Pharms Ltd, Torrent Pharms Ltd, Pharmacia And Upjohn, Teva Pharms Usa, Mylan Pharms Inc, and Apotex Corp, and is included in nine NDAs. There are three patents protecting this compound and two Paragraph IV challenges. Additional information is available in the individual branded drug profile pages.

There are twenty-three drug master file entries for tolterodine tartrate. Twenty suppliers are listed for this compound. There are two tentative approvals for this compound.

Summary for Generic Name: tolterodine tartrate

Tradenames:3
Patents:3
Applicants:7
NDAs:9
Drug Master File Entries: see list23
Suppliers / Packagers: see list20
Bulk Api Vendors: see list97
Clinical Trials: see list198
Patent Applications: see list4,459
Therapeutic Class:Genitourinary Agents
Formulation / Manufacturing:see details
Drug Prices:see low prices
DailyMed Link:tolterodine tartrate at DailyMed

Pharmacology for Ingredient: tolterodine tartrate

Tentative approvals for TOLTERODINE TARTRATE

Applicant Application No. Strength Dosage Form
► Subscribe► Subscribe1MGTABLET; ORAL
► Subscribe► Subscribe2MGTABLET; ORAL
► Subscribe► Subscribe2MGTABLET; ORAL
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Mylan Pharms Inc
TOLTERODINE TARTRATE
tolterodine tartrate
CAPSULE, EXTENDED RELEASE;ORAL201486-002Oct 31, 2013ABRXNoNo► Subscribe► Subscribe► Subscribe
Pharmacia And Upjohn
DETROL LA
tolterodine tartrate
CAPSULE, EXTENDED RELEASE;ORAL021228-002Dec 22, 2000ABRXYesYes► Subscribe► SubscribeY► Subscribe
Teva Pharms Usa
TOLTERODINE TARTRATE
tolterodine tartrate
CAPSULE, EXTENDED RELEASE;ORAL079141-001Nov 22, 2016ABRXNoNo► Subscribe► Subscribe► Subscribe
Mylan Pharms Inc
TOLTERODINE TARTRATE
tolterodine tartrate
CAPSULE, EXTENDED RELEASE;ORAL201486-001Oct 31, 2013ABRXNoNo► Subscribe► Subscribe► Subscribe
Pharmacia And Upjohn
DETROL LA
tolterodine tartrate
CAPSULE, EXTENDED RELEASE;ORAL021228-001Dec 22, 2000ABRXYesNo► Subscribe► SubscribeY► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Expired Orange Book Patents for Generic Ingredient: tolterodine tartrate

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Pharmacia And Upjohn
DETROL
tolterodine tartrate
TABLET;ORAL020771-002Mar 25, 1998► Subscribe► Subscribe
Pharmacia And Upjohn
DETROL LA
tolterodine tartrate
CAPSULE, EXTENDED RELEASE;ORAL021228-001Dec 22, 2000► Subscribe► Subscribe
Pharmacia And Upjohn
DETROL
tolterodine tartrate
TABLET;ORAL020771-001Mar 25, 1998► Subscribe► Subscribe
Pharmacia And Upjohn
DETROL LA
tolterodine tartrate
CAPSULE, EXTENDED RELEASE;ORAL021228-002Dec 22, 2000► Subscribe► Subscribe
Pharmacia And Upjohn
DETROL LA
tolterodine tartrate
CAPSULE, EXTENDED RELEASE;ORAL021228-002Dec 22, 2000► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

Healthtrust
Farmers Insurance
Teva
Medtronic
Citi
UBS
Julphar
Cipla
Baxter
Chubb

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted Heap | Mobile and Web Analytics
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot